Vio3 Apc3 Ej2
Payments companies reported to CMS as associated with Vio3 Apc3 Ej2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3 Apc3 Ej2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3 Apc3 Ej2
These are the largest totals companies reported as associated with Vio3 Apc3 Ej2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Marcia Leung | San Francisco, CA | Gastroenterology (Internal Medicine) | $145.00 |
| Max Goldman | San Francisco, CA | Gastroenterology (Internal Medicine) | $145.00 |
| Ralph Vance | Flowood, MS | Gastroenterology (Internal Medicine) | $134.91 |
| Emily Speer | Wheat Ridge, CO | Surgery | $97.63 |
| Krzysztof Wikiel | Denver, CO | Surgery | $97.63 |
| Edward Jones | Denver, CO | Surgery | $97.63 |
| John Weaver | Denver, CO | Surgery | $97.63 |
| Christopher Thompson | Boston, MA | Gastroenterology (Internal Medicine) | $24.47 |
| Pichamol Jirapinyo | New Haven, CT | Gastroenterology (Internal Medicine) | $24.47 |
Prescribed Vio3 Apc3 Ej2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.